Brief Report: Validation of a Urine Tenofovir Immunoassay for Adherence Monitoring to PrEP and ART and Establishing the Cutoff for a Point-of-Care Test

Monica Gandhi, Peter Bacchetti, Matthew A. Spinelli, +9

JAIDS Journal of Acquired Immune Deficiency Syndromes

Development and validation of the first point-of-care assay to objectively monitor adherence to HIV treatment and prevention in real-time in routine settings

Monica Gandhi, Guohong Wang, R.J.B. King, +13

AIDS

Urine Tenofovir Concentrations Correlate With Plasma and Relate to Tenofovir Disoproxil Fumarate Adherence: A Randomized, Directly Observed Pharmacokinetic Trial (TARGET Study)

Paul K. Drain, Rachel W. Kubiak, Oraphan Siriprakaisil, +12

Clinical Infectious Diseases

A randomized clinical pharmacokinetic trial of Tenofovir in blood, plasma and urine in adults with perfect, moderate and low PrEP adherence: the TARGET study

Tim R. Cressey, Oraphan Siriprakaisil, Virat Klinbuayaem, +8

BMC Infectious Diseases

Plasma pharmacokinetics and urinary excretion of tenofovir following cessation in adults with controlled levels of adherence to tenofovir disoproxil fumarate

Tim R. Cressey, Oraphan Siriprakaisil, Rachel W. Kubiak, +9

International Journal of Infectious Diseases

Tenofovir-Diphosphate in Dried Blood Spots vs Tenofovir in Urine/Plasma for Oral Preexposure Prophylaxis Adherence Monitoring

Xin Niu, Rachel W. Kubiak, Oraphan Siriprakaisil, +7

Open Forum Infectious Diseases